MedPath
HSA Approval

PUSIRAN TABLET 15 mg

SIN02726P

PUSIRAN TABLET 15 mg

PUSIRAN TABLET 15 mg

May 5, 1989

ATLANTIC PHARMACEUTICAL (S) PTE LTD

ATLANTIC PHARMACEUTICAL (S) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantATLANTIC PHARMACEUTICAL (S) PTE LTD
Licence HolderATLANTIC PHARMACEUTICAL (S) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET, SUGAR COATED

ORAL

Medical Information

R05DA09

dextromethorphan

Manufacturer Information

atlantic pharmaceutical (s) pte ltd

ATLANTIC LABORATORIES CORPN LTD

Active Ingredients

DEXTROMETHORPHAN HBr

15 mg

Dextromethorphan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PUSIRAN TABLET 15 mg - HSA Approval | MedPath